GC074 Multiple Joint Pain
Multiple joint pain (polyarthralgia) is the simultaneous or sequential occurrence of pain in several joints, arising from inflammatory, degenerative, autoimmune, infectious, or metabolic causes that require systematic clinical evaluation to identify the underlying etiology.
Multiple Joint Pain: Rheumatoid Arthritis, Osteoarthritis & Spondyloarthritis
This lecture (GC 074) is a cornerstone rheumatology lecture delivered by Dr. Chung Ho Yin from the Division of Rheumatology and Clinical Immunology, HKU. It is one of the most directly examined GC topics in the Fourth Summative, with past-paper SAQs and EMQs pulling content almost verbatim from the slides. [1][2][3]
The big idea: When a patient presents with "multiple joint pain," your job is to classify the arthropathy along two axes — inflammatory vs. non-inflammatory and pattern of joint involvement (mono/oligo/poly; symmetrical vs. asymmetrical; which joints) — and then match that pattern to the correct disease. The three headline conditions are Rheumatoid Arthritis (RA), Osteoarthritis (OA), and Spondyloarthritis (SpA). Understanding the pathophysiology of each explains the clinical features, radiology, serology, and treatment approach.
Learning objectives (from the slides): [1]
- Approach to joint pain
- Rheumatoid Arthritis
- Osteoarthritis
- The concept of Spondyloarthritis
- Disease management
1. Approach to Joint Pain — Classification & Pattern Recognition
The slide's first pass divides inflammatory arthritis (RA, connective-tissue disease, SpA, crystal arthritis) from non-inflammatory causes of joint pain such as OA and fibromyalgia. [1]
Fibromyalgia is a non-inflammatory pain-processing syndrome, not a destructive arthropathy. OA also is not simply passive “wear”: whole-joint biology, including intermittent synovitis and subchondral remodelling, contributes even though the typical clinical pattern is mechanical rather than systemic inflammatory arthritis.
High Yield — Classification Tree
This classification tree from slide 3 is the single most important framework for this lecture. Every subsequent topic hangs off this tree. It has appeared in EMQ stems (e.g., matching clinical features to arthritis type).
Why does the inflammatory vs. non-inflammatory distinction matter?
- Inflammatory arthritis causes pain, stiffness and objective synovitis; persistent RA synovitis can form pannus, erode cartilage/bone and produce irreversible deformity. Prompt specialist assessment and disease-modifying treatment prevent damage.
- OA produces load-related symptoms and whole-joint structural change. Management is not merely analgesia or surgery: education, exercise and weight management when relevant are core treatments. [10]
The lecture's clinical features comparison slide (slide 4) is a classic exam discriminator. [1]
| Feature | RA | SpA | OA | Gout |
|---|---|---|---|---|
| Age | Younger (35–55) | Younger | Older ( > 50) | Middle-aged |
| Onset | Insidious | Insidious | Insidious | Acute |
| Number of joints | Polyarthritis | Mono or polyarthritis | Mono or polyarthritis | Usually monoarthritis |
| Joint pattern | Small hand joints (MCP, PIP, wrist); spares DIP | Any joint; back pain | DIP or weight-bearing joints | 1st MTP classic |
| Morning stiffness | ≥30 min (often > 1h) | Present, improves with exercise | < 30 min | Not prominent |
| Systemic associations | Extra-articular features (nodules, lung, eyes) | Psoriasis, IBD, preceding gastrointestinal/genitourinary infection, uveitis, family history | No defining systemic syndrome | Fever can occur—always consider septic arthritis in a hot swollen joint |
| Course | Progressive if untreated | Variable | Slowly progressive | Usually self-limiting episodes |
Exam Trap — DIP Involvement
RA classically spares the DIP joints. If an exam stem describes DIP involvement, think OA (Heberden's nodes), psoriatic arthritis, or erosive OA. This is a common discriminator. The lecture explicitly highlights this. [1]
Physical exam classifies arthritis by: (1) number — monoarthritis / oligoarthritis / polyarthritis; (2) symmetry — symmetrical vs. asymmetrical; (3) specific joints involved — DIP, MCP, MTP, knee, spine. [1]
Why this matters for diagnosis:
- Symmetrical polyarthritis involving MCP, PIP, wrists, MTP → RA
- Asymmetrical oligoarthritis with axial involvement → SpA
- DIP + weight-bearing joints in elderly → OA
- Monoarthritis (especially acute) → gout, septic arthritis, pseudogout, haemarthrosis
What the Examination Images Add
- Do not count “painful joints” from across the room. Confirm true synovitis by soft, boggy swelling, warmth, tenderness and restricted movement; distinguish it from hard bony enlargement.
- The montage contrasts symmetric RA-pattern polyarthritis with asymmetric SpA-pattern disease. Count the joints, then map which joints are involved.
- The DIP photograph includes nail dystrophy beside distal-joint disease, a visual clue to psoriatic arthritis. The MCP photograph shows established ulnar drift, the first-MTP image shows podagra, and the knee image shows a large effusion. These are pattern clues, not diagnoses in isolation.
- A new hot swollen monoarthritis is septic until adequately assessed. When septic arthritis is suspected, obtain urgent synovial fluid for cell count, Gram stain/culture and crystals, ideally before antibiotics unless the patient is septic and treatment cannot wait. [15]
The concept of arthritis is Inflammation → Joint damages (slide 5). [1]
This is the pathological principle: ongoing inflammation (synovitis) eventually causes structural damage (erosions, deformity, secondary OA). This is why "treat-to-target" strategies aim to suppress inflammation early.
2. Osteoarthritis (OA)
OA is a common cause of non-inflammatory joint pain and its prevalence increases with age. The slide's “75% of women aged ≥65” figure is lecture-era and depends on whether radiographic or symptomatic OA and which joint are measured; do not use it as a universal current prevalence. [1]
Typical sites include knees, hips, spine, DIP/PIP joints and the thumb base (1st CMC/trapeziometacarpal joint). The deck uses “three or more joints” for generalised OA, but definitions vary by study and site set. [1]
Physical exam: crepitus. Primary OA vs secondary OA. [1]
Why these specific joints?
- OA targets joints under maximal mechanical load (knees, hips) or those with unique biomechanical stresses (1st CMC — pinch grip; DIP — terminal loading).
- Primary OA = idiopathic, related to genetics and aging.
- Secondary OA = due to prior injury (fracture, meniscal tear), prior inflammatory arthritis (RA → "burnt out" secondary OA), AVN, Paget's disease. [6]
Heberden's nodes (DIP) and Bouchard's nodes (PIP) are bony swellings of OA — these are osteophytes, NOT synovitis. [6]
The lecture shows a comparison of normal vs. OA femoral head cartilage. [1]
Normal femoral-head cartilage in the gross photograph is smooth and glistening. The OA specimen is irregular, pitted and focally denuded, exposing/remodelling the underlying bone. The paired knee diagram adds capsular thickening, low-grade synovial hypertrophy and these structural responses:
- Sclerosis (increased bone density from attempted repair)
- Cyst formation (synovial fluid intrusion through microfractures)
- Osteophyte formation (new bone at joint margins — the body's attempt to stabilize the joint)
Imaging features of OA: preserved bone density, joint space narrowing (cartilage destruction), sclerosis of subchondral bone, subchondral cysts, marginal osteophytes, joint deformity. [1]
High Yield — OA Radiology Mnemonic: 'LOSS'
L = Loss of joint space (cartilage gone) O = Osteophytes (marginal) S = Subchondral sclerosis S = Subchondral cysts Note: bone density is preserved (unlike RA where there is juxta-articular osteoporosis). This is a key differentiator.
| OA Radiological Feature | Pathological Basis |
|---|---|
| Joint space narrowing | Cartilage destruction |
| Subchondral sclerosis | Reactive bone formation due to increased stress on denuded bone |
| Subchondral cysts | Synovial fluid forced through microcracks into subchondral bone |
| Marginal osteophytes | Attempted repair/stabilization at joint margins |
| Preserved bone density | Reactive subchondral remodelling/sclerosis rather than the periarticular osteopenic pattern of RA |
Reading the radiographs: the knee image demonstrates compartment-predominant joint-space loss with adjacent subchondral sclerosis; the hip image shows severe superior joint-space loss, osteophytes and femoral-head deformity. The lucent rounded area in subchondral bone is a geode/cyst. Unlike RA, OA narrowing is often non-uniform and load-distribution dependent.
3. Rheumatoid Arthritis (RA)
RA is a common autoimmune inflammatory polyarthritis. The slides quote older ancestry-stratified prevalence estimates, a peak onset of 35–55 years and a female predominance. RA can occur in every population and at any adult age; the slide's phrase “rare in blacks” is inaccurate and should not be reproduced as a clinical rule. [1]
Recorded prevalence varies with genetics, smoking and other exposures, age structure, case definition and access to diagnosis. Do not infer an individual's likelihood or disease severity from race.
The lecture shows normal vs rheumatoid synovium. The arthroscopic RA image is red, villous and hypertrophic rather than smooth and pale; histology shows a thickened lining with dense inflammatory cellularity. This proliferative tissue (pannus) invades cartilage and marginal bone. [1]
A useful mechanistic model (not a mandatory linear sequence):
- Genetic susceptibility plus environmental/mucosal exposures—especially smoking—promotes loss of tolerance to modified proteins such as citrullinated antigens.
- ACPA and RF may appear before clinical arthritis, but neither antibody alone causes or proves RA.
- Macrophage, T-cell, B-cell, fibroblast-like synoviocyte and cytokine networks sustain synovitis.
- The synovial lining proliferates into pannus; matrix-degrading enzymes and osteoclast activation damage cartilage and marginal bone.
- Persistent activity produces deformity, secondary OA and disability, which is why early treat-to-target care matters.
RA involves: hands and feet — MCP and PIP, earliest changes in 2nd & 3rd MCP and 3rd PIP; wrists, elbows, knees, ankles, shoulders, hips. Axial skeleton: apophyseal and atlantoaxial joints of cervical spine (C1/2). [1]
High Yield — RA Spares DIP
RA classically spares DIP joints. The earliest radiological changes appear at the 2nd and 3rd MCP joints and 3rd PIP joint. This is extremely high-yield for image interpretation in exams. [1]
C1/2 (atlantoaxial) subluxation in RA is a potentially life-threatening complication — pannus erodes the transverse ligament of C1 → anterior subluxation of C1 on C2 → spinal cord compression. The lecture shows an image of the anterior arch of C1 and odontoid (slide 29). [1]
The lateral radiograph/MRI series is a safety image, not merely an exam sign: neck pain, occipital pain, limb weakness/numbness, gait disturbance or sphincter symptoms in longstanding RA require urgent assessment. Known/suspected cervical instability must be communicated before anaesthesia or procedures involving neck manipulation.
Disease activities: Pain, Swelling, Stiffness (morning), Functional limitation. Assessed by DAS score, CRP/ESR, ultrasound, MRI. [1]
Disease damages: Pain, Deformities (subluxation including C1/2, tendon rupture, dislocation), Secondary OA, Functional limitation. Assessed by X-rays, CT. [1]
This distinction is critical: activity = ongoing inflammation (reversible with treatment); damage = structural destruction (irreversible, needs surgery).
44-Joint Swollen Joint Count
The lecture shows a body diagram of the 44 joints assessed for swelling (slide 17). [1]
The 44-joint count is used to quantify synovitis in RA and is a component of composite disease activity scores (e.g., DAS28 uses a 28-joint subset). The 44 joints assessed bilaterally are: [1]
- Upper limb: sternoclavicular (2), acromioclavicular (2), shoulder (2), elbow (2), wrist (2), MCP 1–5 (10), PIP 1–5 (10)
- Lower limb: knee (2), ankle (2), MTP 1–5 (10)
- Total: 44 joints
Boutonnière deformity, Swan neck deformity, Mallet finger [1]
| Deformity | Mechanism | Appearance |
|---|---|---|
| Boutonnière | Central slip rupture of extensor tendon at PIP → PIP flexion, DIP hyperextension | "Buttonhole" — PIP stuck in flexion |
| Swan neck | Volar plate laxity / FDS rupture → PIP hyperextension, DIP flexion | Elegant S-curve of finger |
| Mallet finger | Terminal extensor tendon failure → DIP flexion | Shown in the lecture's deformity panel, but less characteristic of RA than ulnar drift, swan-neck, boutonnière or Z-thumb and often traumatic |
| Z-thumb (Hitchhiker's) | MCP flexion + IP hyperextension | Thumb looks like giving a thumbs-up |
| Ulnar deviation | MCP subluxation with ulnar drift | Fingers deviate toward ulnar side |
Past paper SAQ (2020) directly asked: "Name four possible deformities in the hands and wrists if the disease further progresses" → Answer: Swan neck, Boutonnière, Z-thumb/hitchhiker's thumb, ulnar deviation of MCP, subluxation of wrist, tendon rupture. [3]
Although not explicitly listed on a single slide, the lecture mentions "extra-articular features" (slide 18). From the senior notes and supporting material: [1][4][5]
| System | Manifestation |
|---|---|
| Skin | Rheumatoid nodules (extensor surfaces, elbows) |
| Eye | Keratoconjunctivitis sicca (2° Sjögren's), scleritis, episcleritis, PUK |
| Lung | Pleural effusion, pulmonary fibrosis, rheumatoid nodules, Caplan syndrome |
| Heart | Pericarditis, cardiac amyloidosis |
| Haem | Anaemia of chronic disease, Felty syndrome (RA + splenomegaly + neutropenia) |
| Neuro | CTS (carpal tunnel), C1/2 myelopathy |
| Vascular | Vasculitis (rare but severe) |
Slide 20 provides approximate frequencies of joint involvement in long-standing RA and a more comprehensive list of extra-articular/systemic manifestations. [1]
Approximate frequency of joint involvement in long-standing RA: [1]
| Joint | Frequency |
|---|---|
| MCP | 80–90% |
| PIP | 80–90% |
| MTP | 80–95% |
| Wrist | 70–80% |
| Knee | 70–85% |
| Glenohumeral (shoulder) | 50–70% |
| Elbow | 40–60% |
| Acromioclavicular | 40–60% |
| Midtarsal | 40–60% |
| Hip | 30–50% |
| Talocrural (ankle) | 30–50% |
| Talocalcaneal | 30–50% |
| Cervical spine | 30–40% |
| Temporomandibular | 25–35% |
| Sternoclavicular | 20–40% |
| Cricoarytenoid | 20–30% |
Additional findings in the lecture's systemic schematic: [1]
- Lymph nodes — reactive lymphadenopathy
- Kidney & gut — secondary AA amyloidosis (now uncommon where inflammation is well controlled); renal disease may instead be drug-related or unrelated
- Bone marrow — anaemia, thrombocytosis
- Muscle — wasting
- Skin — ulceration can reflect vasculitis; skin thinning may be glucocorticoid-related rather than RA itself
- Nervous system — peripheral neuropathy
3G. Serology
RF: auto-antibody against IgG. Not sensitive. No correlation with disease activity. Causes: (1) RA, (2) Sjögren's Syndrome, (3) Chronic infection, (4) Elderly and healthy individuals. High levels in RA → poor prognosis. [1]
Why is RF not specific? The usual assay detects immunoglobulin directed against the Fc portion of IgG. Chronic infection, other autoimmune diseases and healthy ageing can produce positivity, so interpret the titre only in the clinical context of synovitis.
Why is high-titre RF prognostically relevant? High RF correlates with more aggressive disease, extra-articular manifestations (especially vasculitis and nodules), and erosive progression.
Anti-CCP: low sensitivity, HIGH specificity ( > 90% in relevant clinical setting). No correlation with disease activity. Predicts progressive and erosive disease. Specificity further improves if screened together with RF. [1]
High Yield — RF vs ACPA
- RF is supportive but non-specific; a high titre is a poor-prognosis marker.
- Anti-CCP/ACPA is more specific and predicts erosive disease, but a negative result does not exclude RA.
- Neither antibody is a serial activity marker; use a composite score plus clinical assessment and CRP/ESR.
- Testing both can improve classification, but serology must never delay urgent referral for persistent small-joint synovitis. NICE recommends referral even with normal acute-phase markers and negative RF/anti-CCP. [9]
The lecture references the 2010 ACR/EULAR classification criteria (slide 21). [1]
A score ≥ 6/10 classifies a patient as definite RA for the criteria's intended setting if there is clinical synovitis in ≥1 joint not better explained by another disease:
| Domain | Category | Score |
|---|---|---|
| Joint involvement | 1 large joint | 0 |
| 2–10 large joints | 1 | |
| 1–3 small joints (± large) | 2 | |
| 4–10 small joints (± large) | 3 | |
| > 10 joints (≥1 small) | 5 | |
| Serology | RF- and anti-CCP- | 0 |
| Low-positive RF or anti-CCP | 2 | |
| High-positive RF or anti-CCP | 3 | |
| Acute phase reactants | Normal CRP and ESR | 0 |
| Abnormal CRP or ESR | 1 | |
| Duration of symptoms | < 6 weeks | 0 |
| ≥ 6 weeks | 1 |
Classification Is Not Diagnosis
The 2010 ACR/EULAR score supports uniform research classification; it is not a rule-out tool. Early seronegative RA may score below 6. Diagnose clinically, exclude mimics, and refer persistent synovitis promptly. [9]
Radiological features of RA: (1) Soft tissue swelling and widened joint space — synovial inflammation and effusion; (2) Juxta-articular osteoporosis — hyperaemia and disuse; (3) Joint space narrowing — destruction of cartilage by pannus; (4) Periarticular erosions — pannus destruction of unprotected bone at insertion of joint capsule. [1]
High Yield — RA vs OA Radiology Comparison
| Feature | RA | OA |
|---|---|---|
| Bone density | Juxta-articular osteoporosis | Preserved |
| Joint space | Narrowing (uniform) | Narrowing (asymmetric) |
| Erosions | Marginal periarticular erosions | Not typical in ordinary OA; central erosions can occur in erosive hand OA |
| Osteophytes | Absent | Marginal osteophytes |
| Subchondral sclerosis | Minimal | Prominent |
| Subchondral cysts | Can occur | Prominent |
| Soft tissue swelling | Prominent (synovitis) | Minimal |
Past paper (2020 SAQ Q2c): "Name three expected radiological findings in the affected joints" → Periarticular erosions, juxta-articular osteoporosis, joint space narrowing (and/or soft tissue swelling). [3]
Reading the RA Image Sequence
- The early finger films show fusiform soft-tissue swelling and subtle marginal erosions before gross deformity.
- At the MCP heads, look at the bare areas just beyond the cartilage margin for small cortical breaks; these are marginal erosions.
- The advanced bilateral hand film shows uniform joint-space loss, carpal collapse/destruction, MCP subluxation and ulnar drift with relative DIP sparing.
- The wrist close-up shows severe pan-carpal narrowing and erosive destruction. Once this is present, suppressing inflammation can prevent further damage but cannot restore lost architecture—hence the activity-versus-damage distinction.
4. Spondyloarthritis (SpA)
SpA is a family of overlapping disorders that can present predominantly axially or peripherally: psoriatic arthritis, IBD-associated SpA, reactive arthritis and axial SpA. [1]
The lecture diagram places older diagnostic labels on a time arrow toward radiographic sacroiliitis. Do not read it as inevitable linear progression: peripheral and axial manifestations can coexist, and many people with non-radiographic axial SpA never develop radiographic disease. Current terminology distinguishes non-radiographic axial SpA from radiographic axial SpA (traditionally ankylosing spondylitis) by plain-radiograph sacroiliitis—not by calling one an “end stage.”
Why "spondyloarthritis" as a unifying concept? All these conditions share:
- HLA-B27 association
- Enthesitis (inflammation at tendon/ligament insertions)
- Axial involvement (sacroiliitis, spondylitis)
- Peripheral asymmetric arthritis
- Common extra-articular features (uveitis, psoriasis, IBD)
The lecture shows clinical photographs of psoriasis (scaly patches and plaques on the hand), moderate-to-severe nail dystrophy (thickened, discoloured, ridged nail plates with subungual debris), mild nail changes (toenail ridging and discolouration), and dactylitis ("sausage digit" with diffuse fusiform finger swelling). [1]
Key clinical features of PsA to recognise from the photographs: [1]
- Skin: typical erythematous scaly patches and plaques (may be subtle — check scalp, natal cleft, umbilicus)
- Nail changes: pitting, onycholysis, oil-drop discoloration, subungual hyperkeratosis and crumbling. The severe image is not specific enough to exclude onychomycosis; test for fungal infection when clinically relevant.
- Dactylitis ("sausage digit"): diffuse fusiform swelling of an entire digit due to combined flexor tenosynovitis, synovitis, and soft-tissue oedema — highly characteristic of PsA and other SpA
- The dactylitis image shows whole-digit swelling rather than enlargement confined to one joint; nearby small plaques reinforce the psoriasis association.
- The knee photograph shows asymmetric acute synovitis/effusion, a common peripheral-SpA pattern, but a hot swollen knee still requires exclusion of infection and crystals.
- The Achilles photograph localises swelling/tenderness to the tendon insertion. The calcaneal radiograph shows posterior/plantar enthesophytes; these chronic spurs are not specific for active SpA and can occur with mechanical loading.
Clinical features of SpA: Spondylitis, Peripheral arthritis, Enthesitis (Achilles tendinitis, plantar fasciitis), Anterior uveitis, Aortitis. Associated with HLA-B27. Other associated features: psoriasis, inflammatory bowel disease, dysentery, sexually transmitted disease. [1]
High Yield — SpA Features (Past Paper SAQ 2023 Q4a)
The 2023 SAQ asked: "Name four spondyloarthritis features in addition to HLA-B27." Acceptable answers include: inflammatory back pain, sacroiliitis (on imaging), peripheral arthritis, enthesitis (heel), dactylitis, anterior uveitis, psoriasis, IBD, family history of SpA, response to NSAIDs, elevated CRP. [7]
| SpA Subtype | Key Distinguishing Feature |
|---|---|
| Ankylosing Spondylitis | Bilateral sacroiliitis, progressive spinal fusion ("bamboo spine") |
| Psoriatic Arthritis | Skin psoriasis, nail changes, DIP involvement, dactylitis ("sausage digit"), pencil-in-cup deformity |
| Reactive arthritis | Sterile arthritis after gastrointestinal or genitourinary infection; conjunctivitis/uveitis or urethritis may occur, but the historical triad is neither required nor usually complete |
| IBD-associated | Crohn's or UC, arthritis may be independent of bowel disease activity |
HLA-B27: first reported in 1973. ~8–9% of Caucasians carry HLA-B27. Positive in 90–95% of AS patients. Positive in 46–75% of axial SpA patients. HLA-B27 is NOT sensitive or specific in SpA diagnosis. It has a prognostic value. [1]
Three theories for HLA-B27 pathogenesis (slides 41–42): [1] 1. Arthritogenic peptide hypothesis — B27 trimolecular complex presents an "arthritogenic" or "enthesitogenic" peptide to CD8⁺ T cells. 2. Misfolding / UPR hypothesis — B27 heavy chain misfolding during synthesis in ER → unfolded protein response (UPR) → upregulated IL-23 → Th17 cell activation → IL-17 → IL-17-responsive cells release IL-6, IL-1, TNF-α → inflammation. 3. Free heavy-chain homodimer hypothesis — B27 expressed on cell surface as free heavy-chain homodimers → engage KIR and LILR receptors on NK cells, T cells, and B cells → aberrant immune activation. [1]
Exam Trap — HLA-B27 Interpretation
HLA-B27 changes probability only in the right clinical setting. Population prevalence and association strength vary markedly—the world map and B27:04 versus B27:06 peptide-groove diagram explain why one percentage cannot be generalised globally. You cannot diagnose or exclude SpA from HLA-B27 alone, and NICE explicitly says not to rule out SpA after a negative result. [11]
Modified New York Criteria for AS: [1] Clinical criteria: (a) Low back pain and stiffness for > 3 months, improves with exercise, NOT relieved by rest; (b) Limitation of motion of lumbar spine in sagittal AND frontal planes; (c) Limitation of chest expansion relative to age/sex normals. Radiological criteria: sacroiliitis grade ≥2 bilaterally OR grade 3–4 unilaterally. Definite AS = radiological criteria PLUS at least one clinical criterion. [1]
Grading of radiological sacroiliitis: [1]
| Grade | Description |
|---|---|
| 0 | Normal |
| 1 | Suspicious changes |
| 2 | Minimal abnormality — small erosions, sclerosis, no joint space alteration |
| 3 | Unequivocal — moderate/advanced erosions, joint space widening/narrowing, partial ankylosis |
| 4 | Complete ankylosis (fusion) |
The slide's historical “6–11 years” delay illustrates the limitation of waiting for plain-film change. MRI can show inflammation before definite radiographic sacroiliitis, but neither the modified New York nor ASAS criteria are stand-alone diagnostic rules. [11][12]
MRI SI joints with fluid-sensitive sequences can detect subchondral bone-marrow oedema before X-ray changes appear; T1-weighted imaging assesses structural lesions. [1]
Spine MRI findings in SpA — Inflammation: anterior/posterior spondylitis (corner inflammatory lesion [CIL]), spondylodiscitis, costovertebral joint arthritis, zygoapophyseal joint arthritis, enthesitis of spinal ligaments. Structural changes: fatty deposition (fatty corner lesion [FCL]), erosions, syndesmophytes, ankylosis. [1]
The lecture links inflammation → erosion/osteodestruction → repair/new-bone formation. This is a disease model, not a pathognomonic three-image test. [1]
The images show vertebral-corner marrow oedema on fluid-sensitive MRI, structural corner change/erosion, then syndesmophyte formation on radiograph. These lesions are supportive only after considering age, mechanical stress, infection, degeneration and the overall SpA phenotype.
Enthesitis is clinically localised pain/swelling at an insertion (for example Achilles). A calcaneal spur is an enthesophyte indicating chronic traction/remodelling and is not specific for SpA or proof of current inflammation.
MRI Is Supportive, Not Self-Interpreting
In suspected axial SpA, image the sacroiliac joints using an inflammatory-back-pain protocol; spine MRI may add information in selected cases but is not a solitary diagnostic test. Bone-marrow oedema can be mechanical/postpartum or occur in athletes. A negative MRI or HLA-B27 does not end the evaluation when clinical suspicion remains high; NICE advises specialist review and sometimes follow-up MRI. [11][12]
BASDAI is the patient-reported six-question instrument pictured in the lecture. It covers fatigue, axial pain, peripheral pain/swelling, enthesitis and the severity/duration of morning stiffness. [1]
BASDAI is scored 0–10, but a threshold such as ≥4 is a treatment-eligibility convention rather than a diagnosis. Current ASAS–EULAR recommendations prefer ASDAS, which incorporates an acute-phase marker, for disease-activity assessment and treat-to-target decisions. [13]
The lecture dedicates several slides (32–36) to standardised spinal mobility measurements from the ASAS handbook. [1]
These are used to assess and monitor spinal restriction in axial SpA:
| Test | What It Measures | Method (Key Points) |
|---|---|---|
| Modified Schober | Lumbar flexion | Mark at level of PSIS ("dimples of Venus") and 10 cm above; patient bends forward maximally; measure increase in distance (best of 2 tries) |
| Lateral spinal flexion | Lateral lumbar mobility | Heels and back against wall; mark on thigh; bend sideways without bending knees; measure distance change (mean of L + R) |
| Occiput-to-wall distance | Thoracic kyphosis / cervical extension | Heels and back against wall; chin at usual level; try to touch occiput to wall; measure gap (best of 2 tries) |
| Tragus-to-wall distance | Cervical/thoracic mobility | Same position; measure distance from tragus to wall (mean of L + R) |
| Cervical rotation | Cervical spine rotation | Seated; goniometer on top of head aligned with nose; rotate maximally; record angle (mean of L + R; 0–90°) |
| Intermalleolar distance | Hip mobility | Supine (preferred) or standing; legs separated maximally, knees straight; measure distance between medial malleoli |
In advanced AS, severe thoracic and cervical kyphosis develops — the patient is "unable to look ahead while walking" (slide 43). [1]
What the serial examination photographs teach:
- Standardisation matters more than a single cut-off: keep the heels/back positioned as instructed, prevent knee flexion or trunk rotation, take two attempts and record the best/mean exactly as the protocol specifies.
- Modified Schober assesses lumbar flexion; lateral-flexion fingertip excursion assesses coronal mobility; occiput/tragus-to-wall captures fixed kyphosis; cervical rotation uses a goniometer; intermalleolar distance reflects hip abduction.
- These measures monitor mobility and function; none diagnoses axial SpA by itself. Severe fixed kyphosis also creates horizontal-gaze difficulty and a rigid osteoporotic spine that can fracture after minor trauma—new spinal pain after injury warrants urgent imaging.
The lecture presents the ASAS classification criteria (slide 48), which are distinct from the Modified New York Criteria and allow earlier classification. [1]
Axial SpA (back pain ≥ 3 months, onset age < 45 years): [1]
Either:
Sacroiliitis on imaging + ≥1 SpA feature
OR:
HLA-B27 positive + ≥2 other SpA featuresPeripheral SpA (peripheral symptoms only): [1]
Arthritis OR enthesitis OR dactylitis
PLUS either:
≥1 of: uveitis, psoriasis, Crohn's/colitis, preceding infection, HLA-B27, sacroiliitis on imaging
OR:
≥2 of: arthritis, enthesitis, dactylitis, IBP ever, family history of SpASpA features list: inflammatory back pain, arthritis, enthesitis (heel), uveitis, dactylitis, psoriasis, Crohn's/colitis, good response to NSAIDs, family history of SpA, HLA-B27, elevated CRP. [1]
Reported performance: sensitivity 79.5%, specificity 83.3% (n = 975). [1]
ASAS Criteria Are for Classification
The diagram is useful for remembering SpA features, but ASAS criteria were developed to classify research cohorts—not to replace a rheumatologist's diagnostic synthesis. MRI oedema, HLA-B27 or a “good NSAID response” can all mislead when used alone. [12]
| Investigation | What It Tells You | When to Use |
|---|---|---|
| ESR / CRP | Non-specific inflammatory burden | Can be normal in active RA/SpA and raised for unrelated reasons; never use alone to include/exclude a diagnosis |
| RF | Supports seropositive RA and informs prognosis | Test when clinical synovitis suggests RA; positivity is not diagnostic |
| Anti-CCP/ACPA | More specific support for RA; predicts erosive risk | Especially useful when RF is negative, but seronegative RA exists |
| HLA-B27 | Changes pre-test probability of SpA | Order only with a compatible phenotype; neither a screening test nor a stand-alone prognostic label |
| Serum urate | Gout (but can be normal during acute attack) | Crystal arthritis DDx |
| X-ray | Structural damage (erosions, osteophytes, sacroiliitis) | Choose views/site to answer the clinical question; a normal early film does not exclude inflammatory arthritis |
| MRI | Bone marrow, synovial and structural lesions | SI-joint protocol for suspected early axial SpA; interpret in clinical context because marrow oedema is non-specific |
| Ultrasound | Synovitis, effusion, erosions, power Doppler for activity | RA disease activity assessment |
| Joint aspiration | Synovial cell count, Gram stain/culture and crystal analysis | Urgent for suspected septic arthritis; consider when gout/CPPD remains uncertain. Crystals do not exclude concomitant infection. [15] |
6. Treatment
Goals: Suppress disease activity, prevent joint damage, preserve normal function, and pain relief. [1]
Treatment: Education, Physical therapy (physio/OT), Medical therapy, Surgery. [1]
Medications for arthritis: [1] 1. Symptom-modifying anti-rheumatic drug: NSAIDs (e.g., Diclofenac) 2. Disease-modifying anti-rheumatic drug (DMARD): (a) csDMARD: Methotrexate, Sulfasalazine, Leflunomide (b) bDMARD: anti-TNF, anti-IL6, anti-IL17, anti-CD20 (c) tsDMARD: JAK inhibitors (e.g., Tofacitinib) 3. Steroid [1]
High Yield — DMARD Classification
| Category | Examples | Mechanism |
|---|---|---|
| csDMARD | Methotrexate, sulfasalazine, leflunomide, hydroxychloroquine | Conventional systemic immunomodulation; drug choice and monitoring are disease- and patient-specific |
| bDMARD | Anti-TNF, anti-IL-6, anti-IL-17, B-cell depletion and other targets | The targets are not interchangeable across diseases: anti-IL-17 is used in PsA/axSpA, whereas IL-6 blockade and rituximab are RA options |
| tsDMARD | Tofacitinib, Baricitinib (JAK inhibitors) | Block intracellular JAK-STAT signaling |
Methotrexate side effects include hepatotoxicity, bone marrow suppression, oral ulcers (→ treat with folic acid supplementation), and pneumonitis. [2]
JAK inhibitors require specialist risk assessment. MHRA advises avoiding them unless no suitable alternatives exist in people aged ≥65, current/long-term former smokers, or those with cardiovascular or malignancy risk, and cautions about venous thromboembolism and serious infection. [14]
Past paper (2020 EMQ): [2]
- Q1: Ulnar deviation of MCP joints → Hand splint (C)
- Q2: Improve aerobic exercise tolerance → Physiotherapy (G)
- Q3: Not responsive to DMARDs → TNF inhibitors (J)
- Q4: Glucocorticoid-induced osteoporosis → Alendronate (A)
- Q5: Methotrexate-induced oral ulcers → Folic acid (B)
| Disease | First-line | Second-line | Notes |
|---|---|---|---|
| RA | Urgent rheumatology care; start a cDMARD promptly and treat to remission/low activity | Escalate/sequence cDMARDs, bDMARDs or tsDMARDs by response, comorbidity and safety | Methotrexate, leflunomide or sulfasalazine are current NICE first-line monotherapy options; any glucocorticoid bridge should be short and tapered [9][16] |
| OA | Education + tailored therapeutic exercise; weight management when relevant | Topical NSAID (especially knee), then selected oral NSAID with gastroprotection; short-term intra-articular corticosteroid in selected cases | Do not routinely use paracetamol/weak opioids; do not offer strong opioids or intra-articular hyaluronan. Refer for arthroplasty based on symptoms/function despite non-surgical care, not age alone. [10] |
| Axial SpA | Education, regular exercise/physiotherapy and an NSAID if safe | TNF-, IL-17- or selected JAK-pathway therapy for persistently active disease after specialist review | csDMARDs do not treat purely axial disease. Prefer a monoclonal TNF inhibitor with recurrent uveitis/active IBD; IL-17 inhibition can be favoured with major psoriasis. [13] |
| Peripheral SpA/PsA | Treat the dominant domain (peripheral joints, enthesitis, dactylitis, skin/nail, IBD/uveitis) | csDMARD/biologic/targeted therapy chosen for phenotype and comorbidity | Sulfasalazine is not a universal first-line answer; coordinate dermatology/gastroenterology/ophthalmology where relevant. [17] |
Orthopedic surgery considerations — Patient factors: location of damaged joint, expectation of patient, age. Surgeon factors: availability of expertise, previous experience. [1]
From supporting notes: [5]
- Urgent problems: suspected septic arthritis needs immediate specialist management; neurological signs with possible C1/2 instability need urgent spinal assessment.
- Options: synovectomy, tendon reconstruction, decompression, osteotomy, arthrodesis or arthroplasty may be selected according to anatomy, damage and goals.
- Do not use a fixed “lower limb before upper limb” sequence or implant-lifespan promise. Prioritise pain, function, neurological risk, infection, frailty and shared goals.
The lecture shows pre- and post-operative AP knee radiographs (slide 64) demonstrating total knee arthroplasty with alignment reference lines, illustrating surgical correction of a narrowed/irregular medial compartment. [1]
Slide 65 shows a clinical before-and-after comparison of a patient with marked bilateral genu varum (bowed legs) corrected to substantially straighter limb alignment after surgery. [1]
| Related Lecture | Connection |
|---|---|
| GC 075 — Painful Red Joint | Monoarthritis approach: septic arthritis, gout, pseudogout, haemarthrosis. Joint aspiration is the key investigation. [8] |
| GC 031 — Back pain in elderly woman | Osteoporosis and steroid-induced osteoporosis from chronic steroid/DMARD use in RA. [2] |
| GC 053 — Fingers turn white and blue | Other CTD: Scleroderma, Sjögren's (secondary in RA), dermatomyositis. |
| Block A — Facial rash/SLE | SLE arthritis: non-erosive, Jaccoud's arthropathy (reducible deformity). Contrasts with RA (erosive, irreversible). |
| Block A — Hematology Interactive Tutorial | RA patient with anaemia: anaemia of chronic disease vs. NSAID-induced GI bleeding vs. MTX-related marrow suppression. [4] |
High Yield Summary
- Start with the syndrome: confirm objective synovitis, map the number and distribution of affected joints, and treat an acutely hot swollen joint as possible septic arthritis until assessed.
- RA: typically symmetric MCP/PIP/wrist synovitis with DIP sparing. RF and ACPA support—but do not make—the diagnosis. Look for uniform joint-space loss, juxta-articular osteopenia and marginal erosions; refer urgently and use a treat-to-target specialist DMARD strategy.
- OA: usually load-related pain with bony enlargement at DIP/thumb base or weight-bearing joints. LOSS summarises the radiographs: joint-space Loss, Osteophytes, subchondral Sclerosis and Subchondral cysts. Core care is education, exercise and weight management where relevant; topical NSAIDs are useful for knee OA when safe.
- SpA: think axial disease, asymmetric peripheral arthritis, enthesitis, dactylitis, psoriasis/nail disease, anterior uveitis, IBD or preceding gastrointestinal/genitourinary infection. HLA-B27 and SI-joint MRI are supportive, not diagnostic. Exercise/physiotherapy and an NSAID are usual axial first steps; targeted treatment is phenotype- and comorbidity-specific, and csDMARDs do not treat purely axial disease.
Active Recall - Multiple Joint Pain
[1] Lecture slides: GC 074. Multiple joint pain.pdf (slides 1–66) [2] Past papers: 2020 Fourth Summative Assessment MCQ paper.pdf (Section B, EMQ Q1–Q5) [3] Past papers: 2020 Fourth Summative SAQ.pdf (Q2) [4] Senior notes: Block A - Hematology Interactive Tutorial.pdf (RA with anaemia case) [5] Senior notes: Ryan Ho Rheumatology.pdf (p.56, surgical management of RA) [6] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (p.1663, OA overview) [7] Past papers: 2023 Fourth Summative SAQ.pdf (Q4) [8] Lecture slides: GC 075. Pain red joint [Notes].pdf (monoarthritis approach) [9] NICE. Rheumatoid arthritis in adults: management (NG100), current recommendations. https://www.nice.org.uk/guidance/ng100/chapter/recommendations [10] NICE. Osteoarthritis in over 16s: diagnosis and management (NG226), current recommendations. https://www.nice.org.uk/guidance/ng226/chapter/recommendations [11] NICE. Spondyloarthritis in over 16s: diagnosis and management (NG65), current recommendations. https://www.nice.org.uk/guidance/ng65/chapter/recommendations [12] Diekhoff T, et al. MRI in axial spondyloarthritis: understanding an ‘ASAS-positive MRI’ and the ASAS classification criteria. Skeletal Radiology. 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9283193/ [13] Ramiro S, et al. ASAS–EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Annals of the Rheumatic Diseases. 2023. https://www.sciencedirect.com/science/article/abs/pii/S0003496724086205 [14] MHRA. Janus kinase (JAK) inhibitors: new measures to reduce risks of major cardiovascular events, malignancy, venous thromboembolism, serious infections and increased mortality. 2023. https://www.gov.uk/drug-safety-update/janus-kinase-jak-inhibitors-new-measures-to-reduce-risks-of-major-cardiovascular-events-malignancy-venous-thromboembolism-serious-infections-and-increased-mortality [15] Ravn C, et al. Guideline for management of septic arthritis in native joints (SANJO). Journal of Bone and Joint Infection. 2023. https://jbji.copernicus.org/articles/8/29/2023/ [16] Smolen JS, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2025 update. Annals of the Rheumatic Diseases. 2026. https://www.sciencedirect.com/science/article/pii/S0003496726000750 [17] Gossec L, et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the Rheumatic Diseases. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11103320/
GC071 It Is Red And Painful
A clinical approach to the differential diagnosis of a red, painful eye, encompassing conditions such as acute angle-closure glaucoma, anterior uveitis, keratitis, episcleritis, and scleritis that require urgent evaluation.
GC075 Pain Red Joint
A red, swollen, painful joint that requires urgent assessment to exclude septic arthritis, crystal arthropathy, or other serious causes of acute monoarthritis.